scholarly journals Dose–response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults

2012 ◽  
Vol 109 (11) ◽  
pp. 1923-1933 ◽  
Author(s):  
Lynn Cialdella-Kam ◽  
David C. Nieman ◽  
Wei Sha ◽  
Mary Pat Meaney ◽  
Amy M. Knab ◽  
...  
Keyword(s):  
Vitamin C ◽  
Repeated Measures ◽  
Mixed Model ◽  
Linear Mixed Model ◽  
Controlled Trial ◽  
Partial Least Square ◽  
Least Square ◽  
Metabolic Effects ◽  
Mixed Model Analysis ◽  
Metabolite Profiles

Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and 5 mg/d of niacin; Q-1000 = 1000 mg/d of quercetin, 250 mg/d of vitamin C and 10 mg/d of niacin) would alter small-molecule metabolite profiles and serum quercetin conjugate levels in adults. Healthy adults (fifty-eight women and forty-two men; aged 40–83 years) were assigned using a randomised double-blinded placebo-controlled trial to one of three supplement groups (Q-1000, Q-500 or placebo). Overnight fasted blood samples were collected at 0, 1 and 3 months. Quercetin conjugate concentrations were measured using ultra-performance liquid chromatography (UPLC)-MS/MS, and metabolite profiles were measured using two MS platforms (UPLC-quadrupole time-of-flight MS (TOFMS) and GC-TOFMS). Statistical procedures included partial least square discriminant analysis (PLS-DA) and linear mixed model analysis with repeated measures. After accounting for age, sex and BMI, quercetin supplementation was associated with significant shifts in 163 metabolites/quercetin conjugates (false discovery rate, P< 0·05). The top five metabolite shifts were an increase in serum guaiacol, 2-oxo-4-methylthiobutanoic acid, allocystathionine and two bile acids. Inflammatory and oxidative stress metabolites were not affected. PLS-DA revealed a clear separation only between the 1000 mg/d and placebo groups (Q2Y= 0·763). The quercetin conjugate, isorhamnetin-3-glucuronide, had the highest concentration at 3 months followed by quercetin-3-glucuronide, quercetin-3-sulphate and quercetin diglucuronide. In human subjects, long-term quercetin supplementation exerts disparate and wide-ranging metabolic effects and changes in quercetin conjugate concentrations. Metabolic shifts were apparent at the 1000 mg/d dose; further research is required to understand the health implications of these shifts.

scholarly journals Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and individually: a placebo-controlled trial

2017 ◽  
Vol 47 (15) ◽  
pp. 2708-2719 ◽  
Author(s):  
C. Hindocha ◽  
T. P. Freeman ◽  
J. X. Xia ◽  
N. D. C. Shaban ◽  
H. V. Curran
Keyword(s):  
Verbal Memory ◽  
Mixed Model ◽  
Linear Mixed Model ◽  
Controlled Trial ◽  
Subjective Effects ◽  
Preliminary Evidence ◽  
Interactive Effects ◽  
Double Blind ◽  
Mixed Model Analysis ◽  
Psychotomimetic Effects

BackgroundCannabis and tobacco have contrasting cognitive effects. Smoking cannabis with tobacco is prevalent in many countries and although this may well influence cognitive and mental health outcomes, the possibility has rarely been investigated in human experimental psychopharmacological research.MethodThe individual and interactive effects of cannabis and tobacco were evaluated in 24 non-dependent cannabis and tobacco smokers in a randomized, placebo-controlled, double-blind, 2 (cannabis, placebo) × 2 (tobacco, placebo) crossover design. Verbal memory (prose recall), working memory (WM) performance including maintenance, manipulation and attention (N-back), psychotomimetic, subjective and cardiovascular measures were recorded on each of four sessions.ResultsCannabis alone impaired verbal memory. A priori contrasts indicated that tobacco offset the effects of cannabis on delayed recall. However, this was not supported by linear mixed model analysis. Cannabis load-dependently impaired WM. By contrast, tobacco improved WM across all load levels. The acute psychotomimetic effects and ratings of ‘stoned’ and ‘dizzy’ induced by cannabis were not altered by tobacco. Cannabis and tobacco had independent effects on increasing heart rate and interacting effects on increasing diastolic blood pressure.ConclusionsRelative to placebo, acute cannabis impaired verbal memory and WM. Tobacco enhanced performance on WM, independently of cannabis. Moreover, we found some preliminary evidence that tobacco may offset the effects of cannabis on delayed, but not immediate, verbal recall. In contrast, the psychotomimetic and subjective effects of cannabis were unaffected by tobacco co-administration. By reducing the cognitive impairment from cannabis, tobacco co-administration may perpetuate use despite adverse health consequences.

scholarly journals Effect of 6 weeks' consumption of β-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults

2011 ◽  
Vol 107 (7) ◽  
pp. 1037-1047 ◽  
Author(s):  
Karen E. Charlton ◽  
Linda C. Tapsell ◽  
Marijka J. Batterham ◽  
Jane O'Shea ◽  
Rebecca Thorne ◽  
...  
Keyword(s):  
Total Cholesterol ◽  
Repeated Measures ◽  
Mixed Model ◽  
Linear Mixed Model ◽  
Controlled Trial ◽  
Weight Maintenance ◽  
Control Groups ◽  
Regulatory Bodies ◽  
Randomised Controlled ◽  
And Control

Several regulatory bodies have approved a health claim on the cholesterol-lowering effects of oat β-glucan at levels of 3·0 g/d. The present study aimed to test whether 1·5 g/d β-glucan provided as ready-to-eat oat flakes was as effective in lowering cholesterol as 3·0 g/d from oats porridge. A 6-week randomised controlled trial was conducted in eighty-seven mildly hypercholesterolaemic ( ≥ 5 mmol/l and < 7·5 mmol/l) men and women assigned to one of three diet arms (25 % energy (E%) protein; 45 E% carbohydrate; 30 E% fat, at energy requirements for weight maintenance): (1) minimal β-glucan (control); (2) low-dose oat β-glucan (1·5 g β-glucan; oats low – OL) or (3) higher dose oat β-glucan (3·0 g β-glucan; oats high – OH). Changes in total cholesterol and LDL-cholesterol (LDL-C) from baseline were assessed using a linear mixed model and repeated-measures ANOVA, adjusted for weight change. Total cholesterol reduced significantly in all groups ( − 7·8 (sd 13·8) %, − 7·2 (sd 12·4) % and − 5·5 (sd 9·3) % in the OH, OL and control groups), as did LDL-C ( − 8·4 (sd 18·5) %, − 8·5 (sd 18·5) % and − 5·5 (sd 12·4) % in the OH, OL and control groups), but between-group differences were not significant. In responders only (n 60), β-glucan groups had higher reductions in LDL-C ( − 18·3 (sd 11·1) % and − 18·1 (sd 9·2) % in the OH and OL groups) compared with controls ( − 11·7 (sd 7·9) %; P = 0·044). Intakes of oat β-glucan were as effective at doses of 1·5 g/d compared with 3 g/d when provided in different food formats that delivered similar amounts of soluble β-glucan.

scholarly journals Acute Effect of Herbs and Spices Intake on Endothelial Function and Metabolic Markers in Overweight or Obese Adults

2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 324-324
Author(s):  
Yudai Huang ◽  
Meng-Fu Tsai ◽  
Rajrajeshwari Thorat ◽  
Di Xiao ◽  
Xuhuiqun Zhang ◽  
...  
Keyword(s):  
Repeated Measures ◽  
Vascular Function ◽  
Mixed Model ◽  
Health Indicators ◽  
Metabolic Effects ◽  
Bioactive Metabolites ◽  
Secondary Outcome ◽  
Blood Samples ◽  
Mixed Model Analysis ◽  
Herbs And Spices

Abstract Objectives Herbs and Spices (H/S) contain an array of bioactive compounds with purported health benefits. This study investigated the effect of acute H/S intake on vascular and metabolic health indicators, including flow-mediated vasodilation (FMD), glucose control and inflammatory markers over 24 h in overweight or obese individuals. Methods In this randomized, single-blinded, 4-arm, 24-h, crossover clinical trial, subjects (n = 25, age 37 ± 15 years, BMI 28.5 ± 2.8 kg/m2, mean ± SD) consumed a high-fat and high-carbohydrate (HFHC) challenge meal (about 810 kcal) without (control) or with three different combinations of commercially-available H/S: Italian herbs (rosemary, basil, thyme, oregano, and parsley), cinnamon, or pumpkin pie spice (cinnamon, ginger, nutmeg, and allspice) on four separate days at least three days apart. Meals provided 35% of subjects energy to maintain weight and 1 g H/S per 135 kcal. FMD and blood samples were collected at 0, 2, 4, 5.5, 7, and 24 h for endpoint analysis (additional blood samples at 0.5 and 1 h for insulin/glucose). Mixed-model analysis of repeated measures via PROC MIXED PC-SAS 9.4 was performed on primary and secondary outcome variables. FMD was the primary outcome. Results The addition of H/S in HFHC meals significantly reduced postprandial insulin concentrations over 7 h compared to control (P = 0.03) with no significant decrease in glucose (P = 0.17) compared to the control meal. A significant interaction between H/S and age (P = 0.003) suggested benefits of H/S on insulinemia in individuals 41–65 years. Preliminary analysis showed significant effects of test meal (P &lt; 0.05) on plasma interleukin-6 (IL-6). FMD assessment revealed increased %FMD 24 h after H/S consumption compared to the control meal (P = 0.04), suggesting a possible effect of gut microbial-derived H/S bioactive metabolites, which is under study. Conclusions This study demonstrated the vascular and metabolic effects of meals differing in herbs and spices. Herbs and spices may improve vascular function after 24 h consumption and have different potencies on metabolic indices in different age groups in overweight or obese individuals. Funding Sources This project was funded by McCormick Science Institute.

scholarly journals Anti-Fel d1 immunoglobulin Y antibody-containing egg ingredient lowers allergen levels in cat saliva

2019 ◽  
Vol 21 (10) ◽  
pp. 875-881 ◽  
Author(s):  
Ebenezer Satyaraj ◽  
Qinghong Li ◽  
Peichuan Sun ◽  
Scott Sherrill
Keyword(s):  
Treatment Group ◽  
Treatment Period ◽  
Repeated Measures ◽  
Mixed Model ◽  
Linear Mixed Model ◽  
Control Diet ◽  
Baseline Period ◽  
Daily Trial ◽  
Mixed Model Analysis ◽  
Novel Approach

Objectives Fel d1 is the major cat allergen, causing IgE reactions in up to 90% of cat-allergic adults. Fel d1 secreted in saliva is spread to the haircoat during grooming. Current management includes attempts to reduce or eliminate exposure to Fel d1. A novel approach to reducing immunologically active Fel d1 (aFel d1) exposure, which involves binding the Fel d1 with an anti-Fel d1-specific polyclonal egg IgY antibody (sIgY), was evaluated. The hypothesis was that saliva from cats fed diets containing this sIgY would show a significant reduction in aFel d1. Methods Two trials in cats were completed. In trial 1, saliva was collected 0, 1, 3 and 5 h post-feeding during a 2 week baseline and subsequent 6 week treatment period. Trial 2 included a control and treatment group, and saliva was collected once daily. Trial 2 cats were fed the control diet during a 1 week baseline period, and then fed either control or sIgY diet during the 4 week treatment period. Fel d1-specific ELISA was used to measure salivary aFel d1. Data were analysed using repeated-measures ANOVA and a linear mixed-model analysis. Results Salivary aFel d1 decreased post-treatment in both trials. There were no differences in aFel d1 based on time of collection relative to feeding in trial 1. In trial 2, 82% of treatment group cats showed a decrease in aFel d1 of at least 20% from baseline vs just 38% of control cats. Only one (9%) treatment cat showed an increase in aFel d1 vs 63% of control cats. Conclusions and relevance Feeding sIgY significantly reduced aFel d1 in the saliva of cats within 3 weeks. Although additional research is needed, these findings show promise for an alternative approach to the management of allergies to cats.

scholarly journals Robot-Assisted Arm Training in Chronic Stroke: Addition of Transition-to-Task Practice

2019 ◽  
Vol 33 (9) ◽  
pp. 751-761 ◽  
Author(s):  
Susan S. Conroy ◽  
George F. Wittenberg ◽  
Hermano I. Krebs ◽  
Min Zhan ◽  
Christopher T. Bever ◽  
...  
Keyword(s):  
Mixed Model ◽  
Linear Mixed Model ◽  
Controlled Trial ◽  
Chronic Stroke ◽  
Secondary Outcome ◽  
Motor Deficits ◽  
Robot Assisted ◽  
Robotic Training ◽  
Mixed Model Analysis ◽  
Task Training

Background. Robot-assisted therapy provides high-intensity arm rehabilitation that can significantly reduce stroke-related upper extremity (UE) deficits. Motor improvement has been shown at the joints trained, but generalization to real-world function has not been profound. Objective. To investigate the efficacy of robot-assisted therapy combined with therapist-assisted task training versus robot-assisted therapy alone on motor outcomes and use in participants with moderate to severe chronic stroke-related arm disability. Methods. This was a single-blind randomized controlled trial of two 12-week robot-assisted interventions; 45 participants were stratified by Fugl-Meyer (FMA) impairment (mean 21 ± 1.36) to 60 minutes of robot therapy (RT; n = 22) or 45 minutes of RT combined with 15 minutes therapist-assisted transition-to-task training (TTT; n = 23). The primary outcome was the mean FMA change at week 12 using a linear mixed-model analysis. A subanalysis included the Wolf Motor Function Test (WMFT) and Stroke Impact Scale (SIS), with significance P <.05. Results. There was no significant 12-week difference in FMA change between groups, and mean FMA gains were 2.87 ± 0.70 and 4.81 ± 0.68 for RT and TTT, respectively. TTT had greater 12-week secondary outcome improvements in the log WMFT (−0.52 ± 0.06 vs −0.18 ± 0.06; P = .01) and SIS hand (20.52 ± 2.94 vs 8.27 ± 3.03; P = .03). Conclusion. Chronic UE motor deficits are responsive to intensive robot-assisted therapy of 45 or 60 minutes per session duration. The replacement of part of the robotic training with nonrobotic tasks did not reduce treatment effect and may benefit stroke-affected hand use and motor task performance.

scholarly journals Featured Article: Behavior Interventions Addressing Obesity in Rural Settings: The E-FLIP for Kids Trial

2019 ◽  
Vol 44 (8) ◽  
pp. 889-901 ◽  
Author(s):  
David M Janicke ◽  
Crystal S Lim ◽  
Michael G Perri ◽  
Anne E Mathews ◽  
Linda B Bobroff ◽  
...  
Keyword(s):  
Mixed Model ◽  
Linear Mixed Model ◽  
Controlled Trial ◽  
Maintenance Phase ◽  
Significant Group ◽  
Mixed Model Analysis ◽  
Child Body Mass Index ◽  
Rural Settings ◽  
Assessment And Treatment ◽  
Family Based

Abstract Objective To assess the effectiveness of behavioral parent-only (PO) and family-based (FB) interventions on child weight, dietary intake, glycated hemoglobin, and quality of life in rural settings. Methods This study was a three-armed, randomized controlled trial. Participants were children (age 8–12 years) with overweight or obesity and their parents. A FB (n = 88), a PO (n = 78) and a health education condition (HEC) (n = 83) each included 20 group contacts over 1 year. Assessment and treatment contacts occurred at Cooperative Extension Service offices. The main outcome was change in child body mass index z-score (BMIz) from baseline to year 2. Results Parents in all conditions reported high treatment satisfaction (mean of 3.5 or higher on a 4-point scale). A linear mixed model analysis of change in child BMIz from baseline to year 1 and year 2 found that there were no significant group by time differences in child BMIz (year 2 change in BMIz for FB = −0.03 [−0.1, 0.04], PO = −0.01 [−0.08, 0.06], and HEC = −0.09 [−0.15, −0.02]). While mean attendance across conditions was satisfactory during months 1–4 (69%), it dropped during the maintenance phase (42%). High attendance for the PO intervention was related to greater changes in child BMIz (p < .02). Numerous barriers to participation were reported. Conclusion Many barriers exist that inhibit regular attendance at in-person contacts for many families. Innovative delivery strategies are needed that balance treatment intensity with feasibility and acceptability to families and providers to facilitate broad dissemination in underserved rural settings. ClinicalTrials.gov Identifier: NCT01820338.

scholarly journals Change in Waist Circumference With Continuous Use of a Smart Belt: An Observational Study (Preprint)

2018 ◽  
Author(s):  
Myeonggyun Lee ◽  
Jaeyong Shin
Keyword(s):  
Waist Circumference ◽  
Repeated Measures ◽  
Mixed Model ◽  
Linear Mixed Model ◽  
Loss To Follow Up ◽  
Mixed Model Analysis ◽  
New Strategy ◽  
Health Device ◽  
Continuous Use ◽  
Health Insurers

BACKGROUND Health insurers and policymakers are trying to prevent and reduce cardiovascular diseases due to obesity. A smart belt that monitors activity and waist circumference is a new concept for conquering obesity and may be a promising new strategy for health insurers and policymakers. OBJECTIVE This preliminary study evaluated whether the use of a smart belt was associated with a decrease in waist circumference. METHODS In the manufacturer’s database, there were data on a total of 427 men at baseline. A total of 223, 81, and 27 users kept using the smart belt for 4, 8, and 12 weeks, respectively. Paired t tests and repeated measures analysis of variance (ANOVA) were used to identify the change in waist circumference at specified time intervals (at 4, 8, and 12 weeks). In addition, a linear mixed model was used to incorporate all users’ waist circumference data at each time point. Preexisting data on waist circumference and self-reported demographics were obtained from the manufacturer of the smart belt (WELT Corporation, South Korea). RESULTS Compared with baseline, the waist circumference (cm) decreased significantly at all time points: –0.270 for week 4, –0.761 for week 8, and –1.972 for week 12 (all P<.01). Although each paired t test had a different sample size because of loss to follow-up, the differences between baseline and each subsequent week increased. Equal continuous reduction in waist circumference was observed with the ANOVA and mixed model analysis (beta=–0.158 every week). CONCLUSIONS The smart belt is a newly developed, wearable device that measures real-time steps, sedentary time, and waist circumference. In this study, we showed that wearing the smart belt was associated with reducing waist circumference over 12 weeks. This direct-to-consumer smart health device may contribute toward reducing the risk of obesity and related conditions and controlling increasing health costs for health insurers.

scholarly journals Skin Carotenoid Accumulation in Response to a Two-Week Sweet Potato Snack Added to the Usual Diet

2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 121-121
Author(s):  
Taylor Erickson ◽  
Rui Li ◽  
Elizabeth Woods ◽  
Stephanie Dickinson ◽  
Alyce Fly
Keyword(s):  
Sweet Potato ◽  
Repeated Measures ◽  
Fixed Effects ◽  
Mixed Model ◽  
Linear Mixed Model ◽  
Least Square ◽  
Post Intervention ◽  
Change In Mean ◽  
Usual Diet ◽  
Over Time

Abstract Objectives To evaluate changes in skin carotenoid score (SCS) from baseline, during and following a two-week sweet potato snack added to a participant's usual diet. Methods Forty participants were recruited by convenience for a 7-week longitudinal cohort study with a 1-week period to establish baseline SCS, an intervention consisting of a sweet potato snack fed 3 times/week for 2 weeks in the lab while consuming a usual diet outside of the lab, followed by a 4-week monitoring period. SCS were measured 17 times over the study with pressure-mediated reflectance spectroscopy (Veggie Meter). SCS were analyzed using a linear mixed model (LMM) with repeated measures (fixed effects) to determine whether SCS increased from baseline to the follow up points of the intervention and post-intervention periods (α = 0.05). Data were plotted with a Loess line to visualize change over time. Secondary analyses were conducted to determine if baseline SCS affected time to detect differences post-intervention. Baseline SCS tertiles were analyzed using LMM with repeated measures (fixed effects, α = 0.05). Simple differences in least square means were calculated for each tertile at each time point. Results Participants included 28 (72%) females and 11 (28%) males from 20–62 years who identified themselves as “White” (69.2%), “Asian” (23.1%), “Black/African American” (5.1%), and “Other-Latina” (2.6%). Five participants (12.8%) reported a Hispanic ethnicity. Analyses included 39 of 40 original participants, as one withdrew the first week of the study. Change in mean SCS from baseline over time was significant (P &lt; 0.001). While SCS during the intervention period were not significantly higher than baseline (P = 0.271), those at post-intervention were higher (P &lt; 0.001). The Loess line for mean change in SCS from baseline depicted a period of consistent increase from day 26 to day 36, approximately 3 weeks after the start of the intervention. Change in SCS across periods for all tertiles was significant (P &lt; 0.001). Conclusions These data suggest that 3 weeks after the beginning of a two-week intervention may be a period of interest when measuring the efficacy of such an intervention. Additionally, the difference in mean SCS between periods may depend on baseline SCS. Funding Sources This project was funded in part by Indiana University.

Long-term seizure outcomes after pediatric temporal lobectomy: does brain MRI lesion matter?

2019 ◽  
Vol 24 (2) ◽  
pp. 200-208
Author(s):  
Ravindra Arya ◽  
Francesco T. Mangano ◽  
Paul S. Horn ◽  
Sabrina K. Kaul ◽  
Serena K. Kaul ◽  
...  
Keyword(s):  
Repeated Measures ◽  
Mixed Model ◽  
Linear Mixed Model ◽  
Hippocampal Sclerosis ◽  
Brain Mri ◽  
Temporal Lobectomy ◽  
Seizure Freedom ◽  
Seizure Onset

OBJECTIVEThere is emerging data that adults with temporal lobe epilepsy (TLE) without a discrete lesion on brain MRI have surgical outcomes comparable to those with hippocampal sclerosis (HS). However, pediatric TLE is different from its adult counterpart. In this study, the authors investigated if the presence of a potentially epileptogenic lesion on presurgical brain MRI influences the long-term seizure outcomes after pediatric temporal lobectomy.METHODSChildren who underwent temporal lobectomy between 2007 and 2015 and had at least 1 year of seizure outcomes data were identified. These were classified into lesional and MRI-negative groups based on whether an epilepsy-protocol brain MRI showed a lesion sufficiently specific to guide surgical decisions. These patients were also categorized into pure TLE and temporal plus epilepsies based on the neurophysiological localization of the seizure-onset zone. Seizure outcomes at each follow-up visit were incorporated into a repeated-measures generalized linear mixed model (GLMM) with MRI status as a grouping variable. Clinical variables were incorporated into GLMM as covariates.RESULTSOne hundred nine patients (44 females) were included, aged 5 to 21 years, and were classified as lesional (73%), MRI negative (27%), pure TLE (56%), and temporal plus (44%). After a mean follow-up of 3.2 years (range 1.2–8.8 years), 66% of the patients were seizure free for ≥ 1 year at last follow-up. GLMM analysis revealed that lesional patients were more likely to be seizure free over the long term compared to MRI-negative patients for the overall cohort (OR 2.58, p < 0.0001) and for temporal plus epilepsies (OR 1.85, p = 0.0052). The effect of MRI lesion was not significant for pure TLE (OR 2.64, p = 0.0635). Concordance of ictal electroencephalography (OR 3.46, p < 0.0001), magnetoencephalography (OR 4.26, p < 0.0001), and later age of seizure onset (OR 1.05, p = 0.0091) were associated with a higher likelihood of seizure freedom. The most common histological findings included cortical dysplasia types 1B and 2A, HS (40% with dual pathology), and tuberous sclerosis.CONCLUSIONSA lesion on presurgical brain MRI is an important determinant of long-term seizure freedom after pediatric temporal lobectomy. Pediatric TLE is heterogeneous regarding etiologies and organization of seizure-onset zones with many patients qualifying for temporal plus nosology. The presence of an MRI lesion determined seizure outcomes in patients with temporal plus epilepsies. However, pure TLE had comparable surgical seizure outcomes for lesional and MRI-negative groups.

Sign in / Sign up

Export Citation Format

Share Document